Clormezanona [INN-Spanish]
Brand names,
Clormezanona [INN-Spanish]
Analogs
Clormezanona [INN-Spanish]
Brand Names Mixture
Clormezanona [INN-Spanish]
Chemical_Formula
C11H12ClNO3S
Clormezanona [INN-Spanish]
RX_link
No information avaliable
Clormezanona [INN-Spanish]
fda sheet
Clormezanona [INN-Spanish]
msds (material safety sheet)
Clormezanona [INN-Spanish]
Synthesis Reference
No information avaliable
Clormezanona [INN-Spanish]
Molecular Weight
273.737 g/mol
Clormezanona [INN-Spanish]
Melting Point
116.2 oC
Clormezanona [INN-Spanish]
H2O Solubility
2500 mg/L (hardly soluble)
Clormezanona [INN-Spanish]
State
Solid
Clormezanona [INN-Spanish]
LogP
1.208
Clormezanona [INN-Spanish]
Dosage Forms
No information avaliable
Clormezanona [INN-Spanish]
Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Clormezanona [INN-Spanish]
Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Clormezanona [INN-Spanish]
Absorption
No information avaliable
Clormezanona [INN-Spanish]
side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Clormezanona [INN-Spanish]
Patient Information
No information avaliable
Clormezanona [INN-Spanish]
Organisms Affected
Humans and other mammals